MedPath

Effect of ultra-low dose Naloxone on pai

Phase 3
Conditions
Cholecystitis.
Cholecystitis
Registration Number
IRCT20230424057986N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
60
Inclusion Criteria

Candidate for non-emergency laparoscopic cholecystectomy surgery
Age between 30-65 years

Exclusion Criteria

History of psychological illness
Pregnant women
Abuse of alcohol or drugs

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of patients' pain. Timepoint: 2, 6, 12 and 24 hours after surgery. Method of measurement: Based on numerical rating scale of pain (NRS).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath